Answers are grounded in this paper and cite their sources.
Purpose: The EuroQoL-five dimensions-three levels (EQ-5D-3L) utility values vary across regions, hence become non-interchangeable. This study details a methodology to adjust EQ-5D-3L utility values from the published United States (US) scores for use in the United Kingdom (UK) when individual-level patient data (IPD) are inaccessible. Methods: Linear and polynomial regression models were fitted to map the US-derived EQ-5D-3L health state utility weights (HSUWs) into UK values. Model fit was evaluated via visual inspection and coefficient of determination ( R 2 ). The best-fit model was used to develop a utility-adjustment algorithm. Data for external validation of the algorithm were collected through a targeted literature review, which identified studies reporting mean EQ-5D-3L utilities from both the US and UK. The coefficients of the best-fit model were validated against the published mean US and UK utilities, and the algorithm was validated by comparing published and predicted mean UK utilities. Results: The linear model confirmed linearity between US and UK HSUWs, and was the best-fit over the polynomial model, both visually and with R 2 (0.9574 vs 0.9576). Eleven publications (N = 93,625 participants) reporting the mean US and UK EQ-5D-3L utilities based on the valuation of EQ-5D-3L responses were included for validation. The linearity between the published mean US and UK EQ-5D-3L utilities was deemed valid ( R 2 = 0.9955) with similar slopes (1.45 vs 1.39) and intercepts (− 0.43 vs − 0.38) between the linear model and the published utility-based line. The algorithm (Utility UK = [− 0.3813 + 1.3904 × Utility US ]) predicted the mean UK utilities, which marginally differed from the reported mean UK utilities, confirming its validity. Conclusion: A robust method was developed to adjust US-derived EQ-5D-3L utilities and reflect UK preferences. This method helps predict and transpose utilities from the literature across countries as a supporting tool when IPD are unavailable, which is necessary when adapting cost-effectiveness models to different settings.
No takes yet. Share an insight, caveat, or question.
Alsaleh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: